Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Plos Medicine
|
May 14, 2013
Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys
Felicity T Cutts, Hector S Izurieta, Dale A Rhoda
Vaccine
|
November 2, 2010
Application of the immunological disease continuum to study autoimmune and other inflammatory events after vaccination
Helen C Koenig, Andrea Sutherland, Hector S Izurieta, et al.
BMC Public Health
|
January 24, 2025
Differences in influenza testing and treatment in micropolitan versus metropolitan areas in the U.S. using medicare claims data from 2010 to 2016
Alexia Couture, F Scott Dahlgren, Hector S Izurieta, et al.
Vaccine
|
August 10, 2023
Benefit-risk assessment of vaccines
Sonali Kochhar, Hector S Izurieta, Rebecca E Chandler, et al.
NPJ Vaccines
|
February 5, 2026
Quantitative benefit risk analysis for prophylactic vaccines in the context of FDAs benefit risk framework
Hong Yang, Osman N Yogurtcu, Ujwani Nukala, et al.
JAMA Network Open
|
October 6, 2021
Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans
Yinong Young-Xu, Caroline Korves, Jeff Roberts, et al.
The Journal of Infectious Diseases
|
May 3, 2008
Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005
Sandra S Chaves, Penina Haber, Kimp Walton, et al.
Vaccine
|
February 12, 2023
Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Yi-Chun Carol Liu, Flor M Munoz, Hector S Izurieta, et al.
Vaccine
|
August 28, 2025
Innovative use of self-controlled methods for the evaluation of waning effectiveness of the COVID-19 monovalent third dose: comparison with a test-negative design
Caroline Korves, Martin Kulldorff, Abirami S Balajee, et al.
Vaccine
|
September 6, 2025
A review of methodologic & data considerations for vaccine safety surveillance in the wake of the COVID-19 pandemic
Katherine E Mues, Cindy Ke Zhou, Jennifer E Gerber, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Plos Medicine
|
May 14, 2013
Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys
Felicity T Cutts, Hector S Izurieta, Dale A Rhoda
Vaccine
|
November 2, 2010
Application of the immunological disease continuum to study autoimmune and other inflammatory events after vaccination
Helen C Koenig, Andrea Sutherland, Hector S Izurieta, et al.
BMC Public Health
|
January 24, 2025
Differences in influenza testing and treatment in micropolitan versus metropolitan areas in the U.S. using medicare claims data from 2010 to 2016
Alexia Couture, F Scott Dahlgren, Hector S Izurieta, et al.
Vaccine
|
August 10, 2023
Benefit-risk assessment of vaccines
Sonali Kochhar, Hector S Izurieta, Rebecca E Chandler, et al.
NPJ Vaccines
|
February 5, 2026
Quantitative benefit risk analysis for prophylactic vaccines in the context of FDAs benefit risk framework
Hong Yang, Osman N Yogurtcu, Ujwani Nukala, et al.
JAMA Network Open
|
October 6, 2021
Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans
Yinong Young-Xu, Caroline Korves, Jeff Roberts, et al.
The Journal of Infectious Diseases
|
May 3, 2008
Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005
Sandra S Chaves, Penina Haber, Kimp Walton, et al.
Vaccine
|
February 12, 2023
Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Yi-Chun Carol Liu, Flor M Munoz, Hector S Izurieta, et al.
Vaccine
|
August 28, 2025
Innovative use of self-controlled methods for the evaluation of waning effectiveness of the COVID-19 monovalent third dose: comparison with a test-negative design
Caroline Korves, Martin Kulldorff, Abirami S Balajee, et al.
Vaccine
|
September 6, 2025
A review of methodologic & data considerations for vaccine safety surveillance in the wake of the COVID-19 pandemic
Katherine E Mues, Cindy Ke Zhou, Jennifer E Gerber, et al.
Page
of 7